DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis

News provided by

DigiPath, Inc.

Jul 28, 2015, 06:00 ET

LAS VEGAS, July 28, 2015 /PRNewswire/ -- DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGP), is combining efforts with True North Laboratory of Ann Arbor, Michigan, and Romer Labs, a leading global supplier of diagnostic solutions for food-borne pathogens, to investigate the applicability of utilizing Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.

Continue Reading
DigiPath, Inc., through its subsidiary, DigiPath, Corp., creates and markets innovative and reliable digital pathology solutions that empower private and academic institutions with the ability to create, store, manage, analyze, and correlate data collected through virtual microscopy. DigiPath, Inc. digital pathology portfolio includes PathScope(TM), PathCloud(TM), PathReview(TM), and PathConsult(TM) digital platforms to share and store archive tissue images.
DigiPath, Inc., through its subsidiary, DigiPath, Corp., creates and markets innovative and reliable digital pathology solutions that empower private and academic institutions with the ability to create, store, manage, analyze, and correlate data collected through virtual microscopy. DigiPath, Inc. digital pathology portfolio includes PathScope(TM), PathCloud(TM), PathReview(TM), and PathConsult(TM) digital platforms to share and store archive tissue images.

"This joint effort is expected to result in the first validated kit-based assays for food-borne pathogen and mycotoxin quality assurance testing on cannabis," says Dr. Cindy Orser, DigiPath Labs' Chief Science Officer. "As more states approve medical marijuana, the importance of validated studies such as this one planned for quality assurance will become of keen interest to officials from state public health departments who are responsible for ensuring the safety of medical marijuana."

During the one-week study, Dr. Orser of DigiPath Labs and two scientists from Romer Labs will execute the validation studies at True North Laboratory in Ann Arbor, Michigan, where access to marijuana provides the plant matrix to conduct the testing to validate Romer Labs' AgraQuant® Ochratoxin A ELISA System, which is quantitative from 2 to 40 ppb, and its AgraStrip® Aflatoxin Lateral Flow System, which features a 20 ppb aflatoxin cutoff sensitivity, and the fully quantitative AgraStrip® Aflatoxin WATEX test, which utilizes a water-based extraction process. All solutions are capable of quantifying mycotoxins within specifications of Nevada's cannabis quality assurance testing guidelines.  

The study team will also validate Romer Labs' AOAC certified RapidChek® SELECT™ Salmonella and RapidChek® E. Coli O157 test systems for applicability to cannabis safety testing.

For more information about DigiPath Labs, go to http://digipathlabs.com/.

About DigiPath, Inc. (OTCQB: DIGP)
DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath's four business units are DigiPath Labs, TNM News Corp., DigiPath Corp., and DigiPath U.

Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements are based on information available at the time they are made, and are subject to risks and uncertainties that could cause actual performance to differ materially from those stated. For a description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

Contact:

DigiPath, Inc.
Investor Relations
702.209.2429
[email protected]

Logo - http://photos.prnewswire.com/prnh/20140605/94753

SOURCE DigiPath, Inc.